D.E. Shaw & Co
NXTM

D.E. Shaw & Co’s NxStage Medical Inc. NXTM Stock Holding History

D.E. Shaw & Co’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-26,616
Closed -$762K – 4107
2018
Q4 		$762K Sell
26,616
-45,657
-63% -$1.3M ﹤0.01% 2835
2018
Q3 		$2.02M Sell
72,273
-14,444
-17% -$406K ﹤0.01% 2197
2018
Q2 		$2.42M Sell
86,717
-10,760
-11% -$289K ﹤0.01% 2087
2018
Q1 		$2.42M Sell
97,477
-5,438
-5% -$132K ﹤0.01% 1924
2017
Q4 		$2.49M Sell
102,915
-63,859
-38% -$1.68M ﹤0.01% 1980
2017
Q3 		$4.6M Sell
166,774
-64,489
-28% -$1.72M 0.01% 1437
2017
Q2 		$5.8M Sell
231,263
-88,963
-28% -$2.2M 0.01% 1232
2017
Q1 		$8.59M Buy
320,226
+24,732
+8% +$683K 0.02% 964
2016
Q4 		$7.75M Sell
295,494
-20,818
-7% -$515K 0.01% 1091
2016
Q3 		$7.91M Buy
316,312
+71,964
+29% +$1.68M 0.01% 1019
2016
Q2 		$5.3M Sell
244,348
-38,998
-14% -$696K 0.01% 1252
2016
Q1 		$4.25M Buy
283,346
+4,658
+2% +$78.1K 0.01% 1384
2015
Q4 		$6.11M Buy
278,688
+56,930
+26% +$1.06M 0.01% 1266
2015
Q3 		$3.5M Buy
221,758
+2,762
+1% +$44.3K 0.01% 1664
2015
Q2 		$3.13M Buy
218,996
+6,928
+3% +$117K ﹤0.01% 1835
2015
Q1 		$3.67M Buy
212,068
+96,851
+84% +$1.71M 0.01% 1579
2014
Q4 		$2.07M Buy
115,217
+71,815
+165% +$1.16M ﹤0.01% 2257
2014
Q3 		$570K Sell
43,402
-2,314
-5% -$31.2K ﹤0.01% 3250
2014
Q2 		$657K Buy
+45,716
New +$597K ﹤0.01% 3295
2013
Q4 		– Sell
-65,592
Closed -$863K – 4815
2013
Q3 		$863K Sell
65,592
-84,675
-56% -$1.11M ﹤0.01% 3172
2013
Q2 		$2.15M Buy
+150,267
New +$1.89M ﹤0.01% 2049

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

D.E. Shaw & Co's NXTM Position: Q1 2019 in Review

D.E. Shaw & Co sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 26,616 shares — an estimated $762K sold.

D.E. Shaw & Co first reported a position in NXTM in Q2 2013 and held it in 21 quarters. The position peaked at $8.59M in Q1 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • D.E. Shaw & Co reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 26,616 NxStage Medical Inc. shares in Q1 2019, an estimated $762K.
  • D.E. Shaw & Co first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 21 quarters.
  • D.E. Shaw & Co's NxStage Medical Inc. position peaked at $8.59M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.